Literature DB >> 33804963

COVID-19 and Pneumocystis jirovecii Pulmonary Coinfection-The First Case Confirmed through Autopsy.

Ionuț Isaia Jeican1,2, Patricia Inișca3, Dan Gheban4, Flaviu Tăbăran5, Maria Aluaș6, Veronica Trombitas2, Victor Cristea7, Carmen Crivii1, Lia Monica Junie8, Silviu Albu2.   

Abstract

Background: Establishing the diagnosis of COVID-19 and Pneumocystisjirovecii pulmonary coinfection is difficult due to clinical and radiological similarities that exist between the two disorders. For the moment, fungal coinfections are underestimated in COVID-19 patients. Case presentation: We report the case of a 52-year-old male patient, who presented to the emergency department for severe dyspnea and died 17 h later. The RT-PCR test performed at his admission was negative for SARS-CoV-2. Retesting of lung fragments collected during autopsy revealed a positive result for SARS-CoV-2. Histopathological examination showed preexisting lesions, due to comorbidities, as well as recent lesions: massive lung thromboses, alveolar exudate rich in foam cells, suprapleural and intra-alveolar Pneumocystisjirovecii cystic forms, and bilateral adrenal hemorrhage.
Conclusion: COVID-19 and P.jirovecii coinfection should be considered, particularly in critically ill patients, and we recommend the systematic search for P. jirovecii in respiratory samples.

Entities:  

Keywords:  COVID-19; Pneumocystis jirovecii; SARS-CoV-2; autopsy; coinfection; pneumonia

Mesh:

Year:  2021        PMID: 33804963     DOI: 10.3390/medicina57040302

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  7 in total

Review 1.  COVID-19-associated opportunistic infections: a snapshot on the current reports.

Authors:  Amir Abdoli; Shahab Falahi; Azra Kenarkoohi
Journal:  Clin Exp Med       Date:  2021-08-23       Impact factor: 5.057

2.  Successful treatment of a kidney transplant patient with COVID-19 and late-onset Pneumocystis jirovecii pneumonia.

Authors:  Jing Peng; Ming Ni; Dunfeng Du; Yanjun Lu; Juan Song; Weiyong Liu; Na Shen; Xiong Wang; Yaowu Zhu; Bruce A Vallance; Ziyong Sun; Hong Bing Yu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-12-15       Impact factor: 3.944

Review 3.  Fungal Infections in Critically Ill COVID-19 Patients: Inevitabile Malum.

Authors:  Nikoletta Rovina; Evangelia Koukaki; Vasiliki Romanou; Sevasti Ampelioti; Konstantinos Loverdos; Vasiliki Chantziara; Antonia Koutsoukou; George Dimopoulos
Journal:  J Clin Med       Date:  2022-04-04       Impact factor: 4.241

Review 4.  Concurrent Infection with SARS-CoV-2 and Pneumocystis jirovecii in Immunocompromised and Immunocompetent Individuals.

Authors:  Francesca Gioia; Hanan Albasata; Seyed M Hosseini-Moghaddam
Journal:  J Fungi (Basel)       Date:  2022-05-30

5.  Exploring SARS-CoV2 host-pathogen interactions and associated fungal infections cross-talk: Screening of targets and understanding pathogenesis.

Authors:  Abdul Arif Khan; Sudhir K Jain; Mahendra Rai; Samiran Panda
Journal:  Comput Struct Biotechnol J       Date:  2022-08-10       Impact factor: 6.155

Review 6.  The role of SARS-CoV-2 immunosuppression and the therapy used to manage COVID-19 disease in the emergence of opportunistic fungal infections: A review.

Authors:  Nahid Akhtar; Atif Khurshid Wani; Surya Kant Tripathi; Ajit Prakash; M Amin-Ul Mannan
Journal:  Curr Res Biotechnol       Date:  2022-08-03

Review 7.  Fungal Infections Other Than Invasive Aspergillosis in COVID-19 Patients.

Authors:  Kerri Basile; Catriona Halliday; Jen Kok; Sharon C-A Chen
Journal:  J Fungi (Basel)       Date:  2022-01-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.